Natco Pharma schedules 43rd AGM for Sep 30, 2026; approves up to ₹2,000 Cr fundraising
Natco Pharma will hold its 43rd AGM on September 30, 2026, via VC/OAVM. The company plans to raise up to ₹2,000 crores through various fundraising methods including QIP. E-voting is open from September 27 to September 29, 2026.
The approval for raising up to ₹2,000 crores can significantly impact the company's capital structure and future growth prospects. The AGM itself is a standard corporate governance event.
The announcement is a routine corporate event (AGM notice) and a proposal for future fundraising, which is standard business practice. While the fundraising amount is significant, there are no immediate financial results or performance indicators mentioned to suggest a positive or negative sentiment.
Natco Pharma Limited has announced the schedule for its 43rd Annual General Meeting (AGM), which will be held on Wednesday, September 30, 2026, at 11:00 AM IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
The AGM will include ordinary business such as the adoption of audited financial statements for the Financial Year 2025-26 (both standalone and consolidated) and confirmation of interim dividends aggregating ₹5.00 per share paid during FY 2025-26. Additionally, Sri P.S.R.K. Prasad will be considered for re-appointment as a Director liable to retire by rotation.
Special business at the meeting includes the ratification of remuneration for Cost Auditors, M/s. S.S. Zanwar & Associates, amounting to ₹5,00,000 plus applicable taxes and out-of-pocket expenses for the financial year ending March 31, 2027. Furthermore, the company seeks approval to raise funds up to ₹2,000 crores through various methods including preferential issue, rights issue, private placement, and qualified institutions placement (QIP).
The e-voting facility for the AGM will commence on Sunday, September 27, 2026, at 9:00 AM IST and conclude on Tuesday, September 29, 2026, at 5:00 PM IST. The cut-off date for e-voting eligibility is Friday, September 25, 2026.
A plain-language summary of a public exchange filing by Natco Pharma Limited. Read the original for the full detail.
